№ files_lp_3_process_7_049822
Evidence summary presenting quantitative and qualitative findings from multiple countries on the acceptability, continuation, and user characteristics of DMPA-SC as a contraceptive method, including perspectives of women, adolescents, providers, and male partners.
Title: Evidence at-a-glance: Spotlight on Acceptability of DMPA-SC
Product: DMPA-SC (subcutaneous depot medroxyprogesterone acetate)
Type of document: Evidence summary brief
Thematic area: Family planning and contraception
Focus: Acceptability and user preferences
Geographic coverage: Sub-Saharan Africa, Asia, Latin America, Europe, United Kingdom, United States
Countries referenced: Democratic Republic of the Congo, Nepal, Senegal, Uganda, Malawi, Burkina Faso, Niger, India
Target population: Women of reproductive age, including adolescents and young women
Key features: Self-injection option, community-based distribution, room temperature stability (15°C–30°C), three-year shelf life
Effectiveness: 99% effective when administered correctly every three months
Price information: US$0.85 per dose in standard 200-pack presentation for qualified buyers
Publisher / Organization: PATH
Contact information: [email protected]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.